Graduate School of Integrated Sciences for Life, Hiroshima University. 1-4-4 Kagamiyama, Higashi-Hiroshima, 739-8528, Japan.
Institute of Gene Research, Yamaguchi University Science Research Center, 1-1-1 Minami-Kogushi, Ube, 755-8505, Japan.
Arch Biochem Biophys. 2021 Nov 15;712:109044. doi: 10.1016/j.abb.2021.109044. Epub 2021 Sep 28.
The pathogenesis of chronic kidney disease (CKD) is closely related to the changes in the intestinal microbiota and integrity. Our previous studies have shown the accumulation of hydrogen sulfide (HS)-producing bacterial family, Desulfovibrionacea, in the colon of a murine model of CKD, suggesting that the increased HS contributes to the impaired intestinal integrity in CKD. Here, we investigated the anti-proliferative effect of HS in the intestinal epithelial cells. A slow- HS releasing molecule GYY4137 ((p-methoxyphenyl)morpholino-phosphinodithioic acid) reduced the proliferation of Caco-2 and IEC-6 cells. Flow cytometric analysis demonstrated that GYY4137 accumulated Caco-2 cells in the S phase fraction, suggesting that HS arrested the cell cycle at G2 and/or M phases. The RNA sequencing analysis demonstrated that GYY4137 modulated the mRNA expression of the genes involved in the G2/M and the spindle assembly checkpoints; increased mRNA levels of Cdkn1a, Gadd45a, and Sfn and decreased mRNA levels of Cdc20, Pttg1, and Ccnb1 were observed. These alterations were confirmed by quantitative reverse transcription-polymerase chain reaction and Western blot analyses. Besides, studies exploring the MEK inhibitor indicated that MEK activation is involved in the GYY4137-mediated increase in the Sfn expression. Altogether, our data showed that HS reduced the proliferation of intestinal epithelial cells through transcriptional regulation in G2/M and the spindle assembly checkpoints. This may be one of the underlying mechanisms for the observed impaired intestinal integrity in CKD.
慢性肾脏病(CKD)的发病机制与肠道微生物群和完整性的变化密切相关。我们之前的研究表明,在 CKD 小鼠模型的结肠中,产氢硫化物(HS)细菌家族脱硫弧菌的积累,表明增加的 HS 有助于 CKD 中肠道完整性的受损。在这里,我们研究了 HS 对肠道上皮细胞的抗增殖作用。一种缓慢释放 HS 的分子 GYY4137((对甲氧基苯基)吗啉基膦二硫代酸)可降低 Caco-2 和 IEC-6 细胞的增殖。流式细胞术分析表明,GYY4137 将 Caco-2 细胞积累在 S 期分数中,表明 HS 将细胞周期阻滞在 G2 和/或 M 期。RNA 测序分析表明,GYY4137 调节了参与 G2/M 和纺锤体组装检查点的基因的 mRNA 表达;观察到 Cdkn1a、Gadd45a 和 Sfn 的 mRNA 水平增加,而 Cdc20、Pttg1 和 Ccnb1 的 mRNA 水平降低。这些变化通过定量逆转录聚合酶链反应和 Western blot 分析得到了证实。此外,研究探索了 MEK 抑制剂表明,MEK 激活参与了 GYY4137 介导的 Sfn 表达增加。总之,我们的数据表明,HS 通过 G2/M 和纺锤体组装检查点的转录调控降低了肠道上皮细胞的增殖。这可能是 CKD 中观察到的肠道完整性受损的潜在机制之一。